Your browser doesn't support javascript.
A clinical pilot study on the safety and efficacy of aerosol inhalation treatment of IFN-κplus TFF2 in patients with moderate COVID-19
EClinicalMedicine ; 2020.
Article | WHO COVID | ID: covidwho-689222
ABSTRACT
BackgroundThe outbreak of a new coronavirus (SARS-CoV-2) poses a great challenge to global public health New and effective intervention strategies are urgently needed to combat the disease

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Database: WHO COVID Type: Article Journal: EClinicalMedicine Year: 2020